FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783805126> ?p ?o ?g. }

• W2783805126 endingPage "e0005945" @default.
• W2783805126 startingPage "e0005945" @default.
• W2783805126 abstract "Background Soil Transmitted Helminth (STH) infections negatively impact physical and mental development in human populations. Current WHO guidelines recommend morbidity control of these infections through mass drug administration (MDA) using albendazole (ABZ) or mebendazole. Despite major reductions in STH associated morbidity globally, not all programs have demonstrated the expected impact on prevalence of parasite infections. These therapeutic failures may be related to poor programmatic coverage, suboptimal adherence or the exposure of parasites to sub-therapeutic drug concentrations. As part of the DeWorm3 project, we sought to characterize the serum disposition kinetics and pattern of urinary excretion of ABZ and its main metabolites ABZ sulphoxide (ABZSO) and ABZ sulphone (ABZSO2) in humans, and the assessment of the duration and optimal time point where ABZ and/or its metabolites can be measured in urine as an indirect assessment of an individual’s adherence to treatment. Methodology/Principal findings Consecutive venous blood and urine samples were collected from eight (8) human volunteers up to 72 h post-ABZ oral administration. ABZ/metabolites were quantified by HPLC. The ABZSO metabolite was the main analyte recovered both in serum and urine. ABZSO Cmax in serum was 1.20 ± 0.44 μg/mL, reached at 4.75 h post-treatment. In urine, ABZSO Cmax was 3.24 ± 1.51 μg/mL reached at 6.50 h post-ABZ administration. Conclusion/Significance Pharmacokinetic data obtained for ABZ metabolites in serum and urine, including the recovery of the ABZ sulphoxide derivative up to 72 h in both matrixes and the recovery of the amino-ABZ sulphone metabolite in urine samples, are suggesting the possibility of developing a urine based method to assess compliance to ABZ treatment. Such an assay may be useful to optimize ABZ use in human patients. Trial registration ClinicalTrials.gov NCT03192449." @default.
• W2783805126 created "2018-01-26" @default.
• W2783805126 creator A5012544120 @default.
• W2783805126 creator A5026226627 @default.
• W2783805126 creator A5031510146 @default.
• W2783805126 creator A5038468955 @default.
• W2783805126 creator A5043790717 @default.
• W2783805126 creator A5049646080 @default.
• W2783805126 creator A5065954471 @default.
• W2783805126 creator A5076761448 @default.
• W2783805126 creator A5078782756 @default.
• W2783805126 date "2018-01-18" @default.
• W2783805126 modified "2023-10-17" @default.
• W2783805126 title "Assessment of serum pharmacokinetics and urinary excretion of albendazole and its metabolites in human volunteers" @default.
• W2783805126 cites W145726639 @default.
• W2783805126 cites W170835808 @default.
• W2783805126 cites W1900802472 @default.
• W2783805126 cites W1971595135 @default.
• W2783805126 cites W1992190965 @default.
• W2783805126 cites W1994235150 @default.
• W2783805126 cites W2011063359 @default.
• W2783805126 cites W2018847622 @default.
• W2783805126 cites W2037156603 @default.
• W2783805126 cites W2038869189 @default.
• W2783805126 cites W2047110729 @default.
• W2783805126 cites W2056225743 @default.
• W2783805126 cites W2057913937 @default.
• W2783805126 cites W2060205588 @default.
• W2783805126 cites W2083028979 @default.
• W2783805126 cites W2095866940 @default.
• W2783805126 cites W2096773051 @default.
• W2783805126 cites W2097451863 @default.
• W2783805126 cites W2116105693 @default.
• W2783805126 cites W2139791282 @default.
• W2783805126 cites W2151211884 @default.
• W2783805126 cites W2190276977 @default.
• W2783805126 cites W2263290155 @default.
• W2783805126 cites W2272981647 @default.
• W2783805126 cites W2332412585 @default.
• W2783805126 cites W2502670554 @default.
• W2783805126 cites W2607359280 @default.
• W2783805126 cites W2627070840 @default.
• W2783805126 cites W36008106 @default.
• W2783805126 cites W4255814484 @default.
• W2783805126 doi "https://doi.org/10.1371/journal.pntd.0005945" @default.
• W2783805126 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5773000" @default.
• W2783805126 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29346367" @default.
• W2783805126 hasPublicationYear "2018" @default.
• W2783805126 type Work @default.
• W2783805126 sameAs 2783805126 @default.
• W2783805126 citedByCount "20" @default.
• W2783805126 countsByYear W27838051262018 @default.
• W2783805126 countsByYear W27838051262019 @default.
• W2783805126 countsByYear W27838051262021 @default.
• W2783805126 countsByYear W27838051262022 @default.
• W2783805126 countsByYear W27838051262023 @default.
• W2783805126 crossrefType "journal-article" @default.
• W2783805126 hasAuthorship W2783805126A5012544120 @default.
• W2783805126 hasAuthorship W2783805126A5026226627 @default.
• W2783805126 hasAuthorship W2783805126A5031510146 @default.
• W2783805126 hasAuthorship W2783805126A5038468955 @default.
• W2783805126 hasAuthorship W2783805126A5043790717 @default.
• W2783805126 hasAuthorship W2783805126A5049646080 @default.
• W2783805126 hasAuthorship W2783805126A5065954471 @default.
• W2783805126 hasAuthorship W2783805126A5076761448 @default.
• W2783805126 hasAuthorship W2783805126A5078782756 @default.
• W2783805126 hasBestOaLocation W27838051261 @default.
• W2783805126 hasConcept C10146269 @default.
• W2783805126 hasConcept C112705442 @default.
• W2783805126 hasConcept C126322002 @default.
• W2783805126 hasConcept C141071460 @default.
• W2783805126 hasConcept C22979827 @default.
• W2783805126 hasConcept C2777056448 @default.
• W2783805126 hasConcept C2777065887 @default.
• W2783805126 hasConcept C2777477808 @default.
• W2783805126 hasConcept C2780026642 @default.
• W2783805126 hasConcept C71924100 @default.
• W2783805126 hasConcept C98274493 @default.
• W2783805126 hasConceptScore W2783805126C10146269 @default.
• W2783805126 hasConceptScore W2783805126C112705442 @default.
• W2783805126 hasConceptScore W2783805126C126322002 @default.
• W2783805126 hasConceptScore W2783805126C141071460 @default.
• W2783805126 hasConceptScore W2783805126C22979827 @default.
• W2783805126 hasConceptScore W2783805126C2777056448 @default.
• W2783805126 hasConceptScore W2783805126C2777065887 @default.
• W2783805126 hasConceptScore W2783805126C2777477808 @default.
• W2783805126 hasConceptScore W2783805126C2780026642 @default.
• W2783805126 hasConceptScore W2783805126C71924100 @default.
• W2783805126 hasConceptScore W2783805126C98274493 @default.
• W2783805126 hasIssue "1" @default.
• W2783805126 hasLocation W27838051261 @default.
• W2783805126 hasLocation W27838051262 @default.
• W2783805126 hasLocation W27838051263 @default.
• W2783805126 hasLocation W27838051264 @default.
• W2783805126 hasLocation W27838051265 @default.
• W2783805126 hasLocation W27838051266 @default.
• W2783805126 hasOpenAccess W2783805126 @default.
• W2783805126 hasPrimaryLocation W27838051261 @default.

• next